Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature
Deepak Balak, Sascha Gerdes, Aurora Parodi, et al.
Dermatology and Therapy (2020) Vol. 10, Iss. 4, pp. 589-613
Open Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic
Maria Esposito, Anna Campanati, Alessandro Giunta, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 3, pp. 671-681
Open Access | Times Cited: 9
Glycyrol Prevents the Progression of Psoriasis-like Skin Inflammation via Immunosuppressive and Anti-Inflammatory Actions
Yuanyuan Liu, Yanxia Fu, Ziwei Zhu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17335-17335
Open Access | Times Cited: 5
Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet’s disease: A systematic review and meta-analysis
Yuki Iizuka, Kaoru Takase-Minegishi, Lisa Hirahara, et al.
Modern Rheumatology (2021) Vol. 32, Iss. 6, pp. 1153-1162
Closed Access | Times Cited: 12
Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: a real‐life multicenter study
Tuğba Özkök Akbulut, Filiz Topaloğlu Demir, İlteriş Oğuz Topal, et al.
International Journal of Dermatology (2021) Vol. 60, Iss. 9, pp. 1140-1147
Closed Access | Times Cited: 11
Immuno-Modulatory, Anti-Psoriatic Effects and Furanochromone (Khellin and Visnagin) Contents of Ammi Visnaga (L.) Hydeoethanolic Extract
Ez-zahir Abdeljaouad, Ali Lahna, F. Marnissi, et al.
Biomedical & Pharmacology Journal (2022) Vol. 15, Iss. 3, pp. 1623-1635
Open Access | Times Cited: 8
Overview, Management of the Infections in Psoriatic Patients Treated with Systemic Therapies: A lesson from the immunopathogenesis of psoriasis
Anna Balato, Emanuele Scala, Kilian Eyerich, et al.
Dermatology Practical & Conceptual (2023), pp. e2023016-e2023016
Open Access | Times Cited: 4
Tolerability, acceptability, and reproducibility of topical STAR particles in human subjects
Youngeun Kim, Jae Hwan Jung, Andrew R. Tadros, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 4
A review of heart transplant immunosuppressants and nonmelanoma skin cancer
Daphne G. Eckembrecher, Francelia J. Eckembrecher, Isabella Camacho, et al.
Archives of Dermatological Research (2023) Vol. 315, Iss. 9, pp. 2491-2503
Closed Access | Times Cited: 4
Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities
Chandra L Kakarala, Mohammad Hassan, Rishab Belavadi, et al.
Cureus (2021)
Open Access | Times Cited: 10
Long‐term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach
Clara De Simone, Paolo Dapavo, Piergiorgio Malagoli, et al.
International Journal of Dermatology (2022) Vol. 61, Iss. 12, pp. 1543-1551
Open Access | Times Cited: 7
Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris
Akimichi Morita, Yukie Yamaguchi, Chiharu Tateishi, et al.
The Journal of Dermatology (2022) Vol. 49, Iss. 12, pp. 1211-1220
Open Access | Times Cited: 7
Plaque psoriasis with renal dysfunction successfully treated with ixekizumab
Xinyu Zhu, Xiaoyuan Pan, Zhengbang Dong
Hemodialysis International (2024) Vol. 29, Iss. 1, pp. 126-129
Open Access | Times Cited: 1
Short term efficacy of biological treatment for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis
Omar Ismail, Kamel Jaber, Y. Jaber, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 10
Closed Access | Times Cited: 1
Vitamin D and COVID‐19 in an immunocompromised patient with multiple comorbidities—A Case Report
Martina Kralj, Hrvoje Jakovac
Clinical Case Reports (2021) Vol. 9, Iss. 4, pp. 2269-2275
Open Access | Times Cited: 9
A Clinical Trial for the Identification of Metabolic Biomarkers in Hashimoto’s Thyroiditis and in Psoriasis: Study Protocol
Evangelia Sarandi, Sabine Kruger Krasagakis, Dimitris Tsoukalas, et al.
Pathophysiology (2021) Vol. 28, Iss. 2, pp. 291-306
Open Access | Times Cited: 8
Comparative Study on the Clinical Efficacy and Safety of Acitretin and MTX in the Treatment of Pustular Psoriasis by TLR7/MyD88/CXCL16 Pathway
Jiajing Lu, Yu Wang, Ying Li, et al.
Applied Bionics and Biomechanics (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 6
ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
Cristina Membrive-Jiménez, Sayleth Vieira-Maroun, Noelia Márquez-Pete, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2567-2567
Open Access | Times Cited: 3
<p>Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives</p>
E. Mahé
Psoriasis Targets and Therapy (2020) Vol. Volume 10, pp. 45-56
Open Access | Times Cited: 8
Efficacy and safety profile of phosphodiesterase 4 inhibitor in the treatment of psoriasis: A systematic review and meta-analysis of randomized controlled trials
Qin Kang, Jing-si Chen, Huan Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Impact of supplemental essential phospholipids on treatment outcome and quality of life of patients with psoriasis with moderate severity
Shushanik Karapetyan, Hayk Davtyan, Khachik Khachikyan, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 4
Open Access | Times Cited: 4
Sex Differences in Moderate to Severe Psoriasis: Analysis of the Psoriasis Longitudinal Assessment and Registry
Samantha R. Goldburg, Rebecca Chen, Wayne Langholff, et al.
Journal of Psoriasis and Psoriatic Arthritis (2022) Vol. 7, Iss. 3, pp. 132-139
Closed Access | Times Cited: 4
Impact of Functional Polymorphisms on Drug Survival of Biological Therapies in Patients with Moderate-to-Severe Psoriasis
Cristina Membrive-Jiménez, Cristina Pérez-Ramírez, Salvador Arias‐Santiago, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8703-8703
Open Access | Times Cited: 2
Psoriasis comorbidity management in the COVID era: a pressing challenge
Yang Song, Lei Yao, Shanshan Li, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 2
Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
Pau Rosés‐Gibert, F.J. de la Torre Gomar, Amaia Saenz Aguirre, et al.
Psoriasis Targets and Therapy (2022) Vol. Volume 12, pp. 177-185
Open Access | Times Cited: 3
Novel RNA polymerase I inhibitor CX‐5461 suppresses imiquimod‐induced experimental psoriasis
Xiao Wu, Qihui Yin, Jie Wang, et al.
Experimental Dermatology (2022) Vol. 32, Iss. 1, pp. 91-99
Closed Access | Times Cited: 3

Scroll to top